Managing Acute Severe Ulcerative Colitis in the Older Patient: A Growing Concern

Area of Science:

• Gastroenterology
• Geriatric Medicine
• Clinical Pharmacology

Background:

• Increasing prevalence of ulcerative colitis in older adults.
• Older patients often present with comorbidities and frailty, impacting treatment outcomes.
• Conventional ulcerative colitis therapies may pose risks for elderly patients.

Purpose of the Study:

• To address the challenges of treating severe ulcerative colitis in older patients.
• To propose a structured approach for managing acute severe ulcerative colitis in the elderly.
• To highlight the need for tailored therapeutic strategies in frail older adults.

Main Methods:

• Review of current treatment protocols for acute severe ulcerative colitis.
• Analysis of risks and contraindications of standard therapies in older patients.
• Consideration of adjunctive therapies and structured decision-making.

Main Results:

• Standard therapies like systemic steroids, anti-TNF agents, and JAK inhibitors may be contraindicated or carry high risks in older, frail patients.
• Prolonged systemic steroid use can lead to adverse outcomes, especially in patients requiring surgery.
• Adjunctive measures like hyperbaric oxygen therapy and total enteral nutrition show promise.

Conclusions:

• A structured, time-bound decision tree is essential for managing severe ulcerative colitis in older adults.
• Avoiding prolonged systemic steroid exposure is critical for frail patients.
• Exploring adjunctive therapies may offer safer treatment options for this population.